KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Debt Ratio (2016 - 2025)

Historic Debt Ratio for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 0.05.

  • West Pharmaceutical Services' Debt Ratio fell 1459.02% to 0.05 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.05, marking a year-over-year decrease of 1459.02%. This contributed to the annual value of 0.05 for FY2025, which is 1459.02% down from last year.
  • Latest data reveals that West Pharmaceutical Services reported Debt Ratio of 0.05 as of Q4 2025, which was down 1459.02% from 0.05 recorded in Q3 2025.
  • West Pharmaceutical Services' Debt Ratio's 5-year high stood at 0.09 during Q1 2021, with a 5-year trough of 0.02 in Q4 2023.
  • Its 5-year average for Debt Ratio is 0.06, with a median of 0.06 in 2025.
  • As far as peak fluctuations go, West Pharmaceutical Services' Debt Ratio tumbled by 6673.61% in 2023, and later skyrocketed by 19251.17% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Debt Ratio (Quarter) stood at 0.08 in 2021, then fell by 25.14% to 0.06 in 2022, then plummeted by 66.74% to 0.02 in 2023, then surged by 192.51% to 0.06 in 2024, then fell by 14.59% to 0.05 in 2025.
  • Its Debt Ratio stands at 0.05 for Q4 2025, versus 0.05 for Q3 2025 and 0.05 for Q2 2025.